SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-18-014344
Filing Date
2018-11-14
Accepted
2018-11-14 15:59:15
Documents
61
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fcsc-2018093010qx3.htm 10-Q 1013205
2 EXHIBIT 31 fcsc-2018930ex31.htm EX-31 9874
3 EXHIBIT 32 fcsc-2018930ex32.htm EX-32 6942
10 fcsccolorlogoa11.jpg GRAPHIC 74382
11 pipelinegraph093018a01.jpg GRAPHIC 60351
  Complete submission text file 0001628280-18-014344.txt   6262463

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT fcsc-20180930.xml EX-101.INS 1268307
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fcsc-20180930.xsd EX-101.SCH 45772
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fcsc-20180930_cal.xml EX-101.CAL 53508
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fcsc-20180930_def.xml EX-101.DEF 309421
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fcsc-20180930_lab.xml EX-101.LAB 596750
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fcsc-20180930_pre.xml EX-101.PRE 403873
Mailing Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341 484-713-6000
Fibrocell Science, Inc. (Filer) CIK: 0000357097 (see all company filings)

IRS No.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31564 | Film No.: 181183412
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1